Answers are grounded in this paper and cite their sources.
Subjective toxicities are at high risk of under-reporting by physicians, even when prospectively collected within randomized trials. This strongly supports the incorporation of patient-reported outcomes into toxicity reporting in clinical trials.
No takes yet. Share an insight, caveat, or question.
Maïo et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: